Symptomatic Hypertrophic Cardiomyopathy Hcm clinical trials

Explore recruiting symptomatic hypertrophic cardiomyopathy hcm clinical trials.

Recruiting symptomatic hypertrophic cardiomyopathy hcm studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Symptomatic Hypertrophic Cardiomyopathy Hcm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Follow-Up, Open Label, Research Evaluation of Sustained Treatment with Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)

Netherlands, Poland, Portugal, France, Denmark, Germany +6 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of SOtaglifloziN in symptomATic obstructive And non-obstructive Hypertrophic CardioMyopathy (SONATA-HCM)

Italy, Romania, France, Belgium, Sweden, Portugal +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Symptomatic Hypertrophic Cardiomyopathy Hcm trials by city

Symptomatic Hypertrophic Cardiomyopathy Hcm in Toronto Symptomatic Hypertrophic Cardiomyopathy Hcm in Vancouver Symptomatic Hypertrophic Cardiomyopathy Hcm in Montreal Symptomatic Hypertrophic Cardiomyopathy Hcm in Calgary Symptomatic Hypertrophic Cardiomyopathy Hcm in Edmonton Symptomatic Hypertrophic Cardiomyopathy Hcm in Ottawa Symptomatic Hypertrophic Cardiomyopathy Hcm in Winnipeg Symptomatic Hypertrophic Cardiomyopathy Hcm in Quebec City Symptomatic Hypertrophic Cardiomyopathy Hcm in Hamilton Symptomatic Hypertrophic Cardiomyopathy Hcm in Kitchener Symptomatic Hypertrophic Cardiomyopathy Hcm in London Symptomatic Hypertrophic Cardiomyopathy Hcm in Halifax Symptomatic Hypertrophic Cardiomyopathy Hcm in New York Symptomatic Hypertrophic Cardiomyopathy Hcm in Los Angeles Symptomatic Hypertrophic Cardiomyopathy Hcm in Chicago Symptomatic Hypertrophic Cardiomyopathy Hcm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease